Elise Stefanik (R-N.Y.), U.S. congresswoman for the 21st district in upstate New York and third highest-ranking Republican in the House of Representatives, visited independently-owned Condo Pharmacy in Plattsburgh, N.Y., last week in a show of support for the 340B contract pharmacy
…
SPONSORED CONTENT
In 30 minutes, you will learn how to best manage your drug spend: from account set-up and best practices, to purchasing strategies and TPA configurations. We’ll identify the best metrics and KPIs to track. And we’ll show processes covered entities can implement to decrease unnecessary WAC spend.
At the webinar, you will learn:
… 
Federal health officials should not be allowed to craft their own plan to remedy unlawful Medicare Part B drug payments cuts for 340B hospitals since 2018, as the government has not shown how it would stop future illegal payment cuts,
…
SPONSORED CONTENT
In the dynamic world of 340B, identifying and resolving noncompliance issues can be a time-consuming task. Stakeholders can streamline, simplify, and strengthen their 340B operations with solutions from Apexus, which brings together a wealth of knowledge, from credentialing to noncompliance resolution, to help manage a smooth and successful 340B program. Since Apexus established the Apexus Advanced 340B Operations Certificate Program in 2016, 340B stakeholders have relied on the team’s 340B expertise to provide the highest level of insight needed to understand the current 340B landscape, maintain compliance, and manage a 340B program effectively. Now, through the new Covered Entity Refund Service (CRS), Apexus has developed best practices and processes to resolve noncompliance issues quickly, accurately, and efficiently.
Compliance isn’t an option; neither is expertise
The Apexus Advanced 340B Operations Certificate Program, an industry-recognized certification, has provided exclusive advanced operational resources, continuing education, and expert perspective in all aspects of 340B management. Today, more than 2,000 Apexus Certified Experts
…
A federal district judge has accepted a plan that might speed up a decision in the drug industry’s lawsuit challenging an Arkansas law that requires drug makers to honor 340B contract pharmacy arrangements.
U.S. Senior District Judge Billy Roy Wilson
…
The U.S. government and drug makers Novartis and United Therapeutics’ cross-appeals in their 340B contract pharmacy legal dispute have been set for oral arguments in October, marking the first of the closely watched lawsuits to advance to oral arguments at
…
Q: Where did you grow up?
Pittsburgh, Pennsylvania. As my team knows, I love to spot fellow ‘burgh natives in the field.
Q: Where did you
…
The federal government during the past week filed responses to arguments that drug manufacturers AstraZeneca and Lilly made in federal appeals courts in their 340B contract pharmacy lawsuits.
“In enacting the 340B program, Congress was clear that drug manufacturers must
…
Medicare Part D beneficiaries were much less likely to use lower-cost, authorized generic versions of highly expensive hepatitis C drugs Harvoni and Epclusa in 2019 and 2020 than Medicaid beneficiaries, driving up costs for Part D enrollees and the Medicare
…*Sign up for news summaries and alerts from 340B Report
